Vascular imaging: Changing the face of cardiovascular research

Lupus

Volumn 9, Issue 3, 2000, Pages 176-182

  Manzi, Susan ^a,b,c   Kuller, L H ^b   Edmundowicz, D ^a   Sutton Tyrrell, K ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c Suite 502 Liliane Kaufmann Building ^*  (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; SLE; Vascular imaging

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HEART INFARCTION; HUMAN; IMAGING; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034076657     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120300678828217     Document Type: Review

References (72)

1. Vaarala O, Mantarri M, Manninen V et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995; 91: 23-27.
2. Wu R, Nityanand S, Berglund L, Lithell H, Holm G, Lefvert AK. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol 1997; 17: 3159-3163.
3. Vaarala O. Antiphospholipid antibodies and atherosclerosis. Lupus 1996; 5: 442-447.
4. Gharavi AE, Wilson WA. The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome. Lupus 1996; 5: 343-344.
5. Espeland MA, Craven TE, Riley WA, Corson J, Romont A, Furberg CD. Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Stroke 1996; 27: 480-485.
6. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687-702.
7. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87 (Suppl 3)11: 56-65.
8. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus; quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 1981; 70: 775-781.
9. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 1975; 58: 243-264.
10. Fukumoto S, Tsumagari T, Kinjo M, Tanaka K. Coronary atherosclerosis in patients with systemic lupus erythematosus at autopsy. Acta Pathol Jpn 1987; 37: 1-9.
11. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis 1983; 3: 187-198.
12. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 513-519.
13. Hochberg MC, Petri M. The association of corticosteroid (CS) therapy with coronary heart disease (CHD) in patients with systemic lupus erythematosus (SLE): a meta-analysis. Arthritis Rheum 1991; 34: R24.
14. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995; 92: 2333-2342.
15. Little WC, Constantinescu M, Applegate RJ et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78: 1157-1166.
16. Ambrose JA, Tannenbaum MA, Alexopoulos D et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 56-62.
17. Kullo U, Edwards WD, Schwartz RS. Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med 1998; 129: 1050-1060.
18. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
19. Badui E, Garcia-Rubi D, Robles E et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985; 36: 431-441.
20. Hosenpud JD, Montanaro A, Hart MV et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 1984; 77: 286-292.
21. Bruce IN, Burns RJ, Gladman DD, Urowitz MB. High prevalence of myocardial perfusion abnormalities in women with SLE. Arthritis Rheum 1997; 40 (Suppl 9): S219 (abstract).
22. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335: 1424-1430.
23. Agatston AS, Janowitz WR, Kaplan G, Gasso J, Hildner F, Viamonte M Jr. Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis. Am J Cardiol 1994; 74: 1272-1274.
24. Kaufmann RB, Sheedy PF 2nd, Maher JE et al. Quantity of coronary artery calcium detected by electron beam computed tomography in asymptomatic subjects and angiographically studied patients. Mayo Clin Proc 1995; 70: 223-232.
25. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995; 92: 2157-2162.
26. Mintz GS, Pichard AD, Popma JJ et al. Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol 1997; 29: 268-274.
27. Maher JE, Bielak LF, Raz JA, Sheedy PF 2nd, Schwartz RS, Peyser PA. Progression of coronary artery calcification: a pilot study. Mayo Clin Proc 1999; 74: 347-355.
28. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis of histopathological correlation. Circulation 1993; 87: 1179-1187.
29. Demer LL. Lipid hypothesis of cardiovascular calcification. Circulation 1997; 95: 297-298.
30. Goffman JW. The quantitative nature of the relationship of coronary atherosclerosis and coronary heart disease. Cardiol Digest 1969; 4: 28-38.
31. Mahoney LT, Burns TL, Stanford W et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol 1996; 27: 277-284.
32. Achenbach S, Moshage W, Ropers D, Nossen J, Daniel WG. Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary-artery stenoses and occlusions. N Engl J Med 1998; 339: 1964-1971.
33. Von Felt JM. Coronary electron beam computed tomography (EBCT) in 13 SLE patients with 2 or more cardiovascular risk factors. Arthritis Rheum 1998; 41: S139 (abstract).
34. Skinner MP, Yuan C, Mitsumori L et al. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med 1995; 1: 69-73.
35. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996; 94: 932-938.
36. Bots ML, Hofman A, de Jong PT, Grobbee DE. Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery. The Rotterdam Study. Ann Epidemiol 1996; 6: 147-153.
37. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134: 250-256.
38. O'Leary DH, Polak JF, Wolfson SK Jr et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. Stroke 1991; 22: 1155-1163.
39. The ACAPS Group. Rationale and design for the Asymptomatic Carotid Artery Plaque Study (ACAPS). Control Clin Trials 1992; 13: 293-314.
40. Chambless LE, Heiss G, Folsom AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494.
41. Li R, Cai J, Tegeler C, Sorlie P, Metcalf PA, Heiss G. Reproducibility of extracranial carotid atherosclerotic lesions assessed by B-mode ultrasound: the Atherosclerosis Risk in Communities Study. Ultrasound Med Biol 1996; 22: 791-799.
42. Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima media thickness and atherosclerosis. Direct and indirect validation. Arterioscler Thromb 1994; 14: 261-264.
43. Sutton-Tyrrell K, Wolfson SK, Jr., Thompson T, Kelsey SF. Measurement variability in duplex scan assessment of carotid atherosclerosis. Stroke 1992; 23: 215-220.
44. Furberg CD, Adams HP Jr, Applegate WB etl al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994; 90: 1679-1687.
45. Crouse JR III, Byington RP, Bond MG et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol 1995; 75: 455-459.
46. Roman MJ, Salmon J, Sobel R, Sammaritano L, Devereux RB, Lockshin MD. Premature atherosclerosis and myocardial hypertrophy in SLE and antiphospholipid antibody syndrome. Arthritis Rheum 1997; 40 (Suppl 9): S302 (abstract).
47. Celermajer DS. Endothelial dysfunction: Does it matter? Is it reversible? JACC 1997; 30: 325-333.
48. Celermajer DS, Adams MR, Clarksor. P et al. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults. N Engl J Med 1996; 334: 150-154.
49. Vita JA, Treasure CB, Nabel EG et al. Coronary vasomotor response to acetylcholine relates to factors for coronary artery disease. Circulation 1990; 81: 491-497.
50. Vanhoutte PM. Endothelium and control of vascular function. State of the Art lecture. Hypertension 1989; 13: 658-667.
51. Luscher TF, Richard V, Tschudi M, Yang ZH, Boulanger C. Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol 1990; 15: 519-527.
52. Moncada S, Radomski MW, Palmer RM. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37: 2495-2501.
53. Taddei S, Virdis A, Ghiadoni E et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28: 576-582.
54. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786-791.
55. Eieberman EH, Gerhard MD, Uehata A et al. Estrogen improves endothelium-dependent, floe-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121: 936-941.
56. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO 3rd. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997; 96: 2795-2801.
57. Lakatta EG, Mitchell JH, Pomerance A, Rowe GG. Human aging: changes in structure and function. J. Am Coll Cardiol 1987; 10: 42A-47A.
58. Gribbin B, Pickering TG, Sleight P. Arterial distensibility in normal and hypertensive man. Clin Sci 1979; 56: 413-417.
59. Green MA, Friedlander R, Boltax AJ. Distensibility of arteries in human hypertension. Proc Soc Exp Biol Med 1966; 121: 580-585.
60. Simon AC, Laurent S, Levenson JA, Bouthier JE, Safar ME. Estimation of forearm arterial compliance in normal and hypertensive men from simultaneous pressure and flow measurements in the brachial artery, using a pulsed Doppler device and a first-order arterial model during diastole. Cardiovasc Res 1983; 17: 331-338.
61. Safar ME, Peronneau PA, Levenson JA, Toto-Moukouo JA, Simon AC. Pulsed Doppler: diameter, blood flow velocity and volemic flow of the brachial artery in sustained essential hypertension. Circulation 1981; 63: 393-400.
62. Van Merode T, Hick PJ, Hoeks AP, Rahn KH, Reneman RS. Carotid artery wall properties in normotensive and borderline hypertensive subjects of various ages. Ultrasound Med Biol 1988; 14: 563-569.
63. Avolio AP, Deng FQ, Li WQ et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985; 71: 202-210.
64. Avolio AP, Clyde KM, Beard TC, Cooke HM, Ho KK, O'Rourke MF. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986; 6: 166-169.
65. Toto-Moukouo JJ, Achimastos A, Asmar RG, Hugues CJ, Safar ME. Pulse wave velocity in patients with obesity and hypertension. Am Heart J 1986; 112: 136-140.
66. Stella A, Gessaroli M, Cifiello BI et al. Elastic modulus in young diabetic patients (ultrasound measurements of pulse wave velocity). Angiology 1984; 35: 729-734.
67. Airaksinen KE, Salmela PI, Linnaluoto MK, Ikaheimo MJ, Ahola K, Ryhanen LJ. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res 1993; 27: 942-945.
68. Taquet A, Bonithon-Kopp C, Simon A et al. Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol 1993; 9: 298-306.
69. Amar J, Chamontin B, Pelissier M, Garelli I, Salvador M. Influence of glucose metabolism on nycthemeral blood pressure variability in hypertensives with an elevated waist-hip ratio. A link with arterial distensibility. Am J Hypertension 1995; 8: 426-428.
70. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Circulation 1995; 91: 1432-1443.
71. Kupari M, Hekali P, Keto P, Poutanen VP, Tikkanen MJ, Standertskjold-Nordenstam CG. Relation of aortic stiffness to factors modifying the risk of atherosclerosis in healthy people. Arterioscler Thromb 1994; 14: 386-394.
72. Selzer F, Sutton-Tyrrell K, Fitzgerald S, Kuller L, Manzi S. Risk factors associated with arterial stiffness in women with SLE. Arthritis Rheum 1998; 41: S139 (abstract).